Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 12INDUSTRY 3NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Inflammation 3Vasculitis 2Uveitis 2Granulomatosis with Polyangiitis 2Arthritis, Juvenile 2Temporomandibular Joint Disorders 1Stomatitis 1Pneumonia 1Neoplasms 1Metabolic Syndrome 1Lupus Nephritis 1Asthma 1Arthritis, Rheumatoid 1

Interventions

cabozantinib 1Specimen Handling 1Platinum Compounds 1Nivolumab 1Ipilimumab 1Etanercept 1CTLA-4 Antigen 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Arthritis, Rheumatoid × Etanercept × Clear all
NCT00837434 2021-09-22

Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 4 Completed
63 enrolled 26 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡